Connect
MJA
MJA

Australian standards of care and treatment guidelines for transgender and gender diverse children and adolescents

Michelle M Telfer, Michelle A Tollit, Carmen C Pace and Ken C Pang
Med J Aust 2018; 209 (3): . || doi: 10.5694/mja17.01044
Published online: 18 June 2018

Abstract

Introduction: The Australian standards of care and treatment guidelines aim to maximise quality care provision to transgender and gender diverse (TGD) children and adolescents across Australia, while recognising the unique circumstances of providing such care to this population. Recommendations are made based on available empirical evidence and clinician consensus, and have been developed in consultation with Australian professionals from multiple disciplines working with the TGD population, TGD support organisations, as well as TGD children and adolescents and their families.

Main recommendations: Recommendations include general principles for supporting TGD children and adolescents using an affirmative approach, separate guidelines for the care of pre-pubertal children and TGD adolescents, as well as discipline-based recommendations for mental health care, medical and surgical interventions, fertility preservation, and speech therapy.

Changes in management as a result of this statement: Although published international treatment guidelines currently exist, challenges in accessing and providing TGD health care specific to Australia have not been addressed to date. In response to this, these are the first guidelines to be developed for TGD children and adolescents in Australia. These guidelines also move away from treatment recommendations based on chronological age, with recommended timing of medical transition and surgical interventions dependent on the adolescent’s capacity and competence to make informed decisions, duration of time on puberty suppression, coexisting mental health and medical issues, and existing family support.


  • 1 Royal Children's Hospital Melbourne, Melbourne, VIC
  • 2 Murdoch Children's Research Institute, Melbourne, VIC


Correspondence: michelle.telfer@rch.org.au

Competing interests:

No relevant disclosures.

  • 1. Couch M, Pitts M, Mulcare H, et al. Tranznation: a report on the health and wellbeing of transgendered people in Australia and New Zealand. Melbourne: Australian Research Centre in Sex, Health and Society, La Trobe University, 2007.
  • 2. Giordano S. Children with gender identity disorder: a clinical, ethical, and legal analysis. Oxon, UK: Routledge, 2013.
  • 3. Hillier L, Jones T, Monagle M, et al. Writing Themselves in 3: the third national study on the sexual health and wellbeing of same sex attracted and gender questioning young people. Melbourne: Australian Research Centre in Sex, Health and Society, La Trobe University, 2010.
  • 4. Hyde Z, Doherty M, Tilley P, et al. The First Australian National Trans Mental Health Study: summary of results. Perth: Curtin University, 2014.
  • 5. Strauss P, Cook A, Winter S, et al. Trans Pathways: the mental health experiences and care pathways of trans young people. Summary of results. Perth: Telethon Kids Institute, 2017.
  • 6. Telfer M, Tollit M, Feldman D. Transformation of health-care and legal systems for the transgender population: the need for change in Australia. J Paediatr Child Health 2015; 51: 1051-1053.
  • 7. Clark T, Lucassen M, Bullen P, et al. The health and well-being of transgender high school students: Results from the New Zealand adolescent health survey (Youth’12). J Adolesc Health 2014; 55: 93-99.
  • 8. Coleman E, Bockting W, Botzer M, et al. Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7. Int J Transgend 2012; 13: 165-232.
  • 9. Hembree WC, Cohen-Kettenis PT, Gooren L, et al. Endocrine treatment of gender-dysphoric/gender-incongruent persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2017; 102: 3869-3903.
  • 10. Strang JF, Meagher H, Kenworthy L, et al. Initial clinical guidelines for co-occurring autism spectrum disorder and gender dysphoria or incongruence in adolescents. J Clin Child Adolesc Psychol 2018; 47: 105-115.
  • 11. Bockting WO, Goldberg J. Guidelines for transgender care. Binghamton, NY: Haworth Medical Press, 2006.
  • 12. Adler RK, Hirsch S, Mordaunt M. Voice and communication therapy for the transgender/transsexual client: a comprehensive clinical guide. San Diego, CA: Plural Publishing, 2012.
  • 13. Finlayson C, Johnson EK, Chen D, et al. Proceedings of the working group session on fertility preservation for individuals with gender and sex diversity. Transgend Health 2016; 1: 99-107.
  • 14. American Psychological Association. Report of the Task Force on Gender Identity and Gender Variance. Washington, DC: APA; 2009.
  • 15. Burnes TR, Singh AA, Harper A, et al. American Counseling Association: competencies for counseling with transgender clients. J LGBT Issues Couns 2010; 4: 135-159.
  • 16. Hidalgo MA, Ehrensaft D, Tishelman AC, et al. The gender affirmative model: what we know and what we aim to learn. Hum Dev 2013; 56: 285-290.
  • 17. de Vries A, McGuire J, Steensma T, et al. Young adult psychological outcome after puberty suppression and gender reassignment. Pediatrics 2014; 134: 696-704.
  • 18. Simons L, Schrager S, Clark L, et al. Parental support and mental health among transgender adolescents. J Adolesc Health 2013; 53: 791-793.
  • 19. Olson K, Durwood L, DeMeules M, McLaughlin K. Mental health of transgender children who are supported in their identities. Pediatrics 2016; 137: e20153223.
  • 20. Costa R, Dunsford M, Skagerberg E, et al. Psychological support, puberty suppression, and psychosocial functioning in adolescents with gender dysphoria. J Sex Med 2015; 12: 2206-2214.
  • 21. De Vries AL, Steensma TD, Doreleijers TA, Cohen-Kettenis PT. Puberty suppression in adolescents with gender identity disorder: A prospective follow-up study. J Sex Med 2011; 8: 2276-2283.
  • 22. De Vries AL, McGuire JK, Steensma TD, et al. Young adult psychological outcome after puberty suppression and gender reassignment. Pediatrics 2014; 134: 696-704.
  • 23. Delemarre-van de Waal HA, Cohen-Kettenis PT. Clinical management of gender identity disorder in adolescents: A protocol on psychological and paediatric endocrinology aspects. Eur J Endocrinol 2006; 155(suppl 1): S131-S137.
  • 24. Tack LJ, Heyse R, Craen M, et al. Consecutive cyproterone acetate and estradiol treatment in late-pubertal transgender female adolescents. J Sex Med 2017; 14: 747-757.
  • 25. Durwood L, McLaughlin KA, Olson KR. Mental health and self-worth in socially transitioned transgender youth. J Am Acad Child Adolesc Psychiatry 2017; 56: 116-123 e2.
  • 26. Schagen SE, Cohen-Kettenis PT, Delemarre-van de Waal HA, Hannema SE. Efficacy and safety of gonadotropin-releasing hormone agonist treatment to suppress puberty in gender dysphoric adolescents. J Sex Med 2016; 13: 1125-1132.
  • 27. Vlot MC, Klink DT, den Heijer M, et al. Effect of pubertal suppression and cross-sex hormone therapy on bone turnover markers and bone mineral apparent density (BMAD) in transgender adolescents. Bone 2016; 95: 11-19.
  • 28. Rieger E, editor. Abnormal psychology: leading researcher perspectives. 4th ed. Sydney: McGraw-Hill Education, 2017.
  • 29. Deutsch MB, Buchholz D. Electronic health records and transgender patients—practical recommendations for the collection of gender identity data. J Gen Intern Med 2015; 30: 843-847.
  • 30. Riggs DW, Coleman K, Due C. Healthcare experiences of gender diverse Australians: a mixed-methods, self-report survey. BMC Public Health 2014; 14: 230-234.
  • 31. Cohen-Kettenis PT, Steensma TD, de Vries AL. Treatment of adolescents with gender dysphoria in the Netherlands. Child Adolesc Psychiatr Clin N Am 2011; 20: 689-700.
  • 32. Gelder MG, Marks IM. Aversion treatment in transvestism and transsexualism. In: Green R, Money J, editors. Transsexualism and sex reassignment. Baltimore, MD: Johns Hopkins Press, 1969.
  • 33. Substance Abuse and Mental Health Services Administration. Ending conversion therapy: supporting and affirming LGBTQ youth, HHS Publication No. (SMA) 15-4928. Rockville, MD: SAMHSA, 2015.
  • 34. American Psychological Association. Report of the American Psychological Association Task Force on appropriate therapeutic responses to sexual orientation. Washington, DC: APA; 2009.
  • 35. Drescher J. Controversies in gender diagnoses. LGBT Health 2013; 1: 10-14.
  • 36. Smith E, Jones T, Ward R, et al. From blues to rainbows: the mental health and well-being of gender diverse and transgender young people in Australia. Melbourne: Australian Research Centre in Sex, Health and Society, 2014.
  • 37. Kerry SC. Sistergirls/brotherboys: the status of indigenous transgender Australians. Int J Transgend 2014; 15: 173-186.
  • 38. Re Alex: Hormonal Treatment for Gender Identity Dysphoria [2004] FamCA 297 (13 April 2004). http://www.austlii.edu.au/cgi-bin/viewdoc/au/cases/cth/FamCA/2004/297.html?context=1 (viewed Feb 2018).
  • 39. Re: Jamie [2013] FamCAFC 110 (31 July 2013). http://www.austlii.edu.au/cgi-bin/viewdoc/au/cases/cth/FamCAFC/2013/110.html?context=1; (viewed Feb 2018).
  • 40. Re: Kelvin [2017] FamCAFC 258 (30 November 2017). http://www.austlii.edu.au/cgi-bin/viewdoc/au/cases/cth/FamCAFC/2017/258.html?context=1 (viewed Feb 2018).
  • 41. Light A, Obedin-Maliver J, Sevelius J, Kerns J. Transgender men who experienced pregnancy after female-to-male gender transitioning. Obstet Gynecol 2014; 124: 1120-1127.
  • 42. Thiagaraj D, Gunasegaram R, Loganath A, et al. Histopathology of the testes from male transsexuals on oestrogen therapy. Ann Acad Med Singapore 1987; 16: 347-348.
  • 43. Schulze C. Response of the human testis to long-term estrogen treatment: morphology of Sertoli cells, Leydig cells and spermatogonial stem cells. Cell Tissue Res 1988; 251: 31-43.
  • 44. Lubbert H, Leo-Rossberg I, Hammerstein J. Effects of ethinyl estradiol on semen quality and various hormonal parameters in a eugonadal male. Fertil Steril 1992; 58: 603-608.
  • 45. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th Edition. Arlington, VA: American Psychiatric Association; 2013.
  • 46. Kreukels BP, Cohen-Kettenis PT. Puberty suppression in gender identity disorder: the Amsterdam experience. Nat Rev Endocrinol 2011; 7: 466-472.
  • 47. Mahfouda S, Moore JK, Siafarikas A, et al. Puberty suppression in transgender children and adolescents. Lancet Diabetes Endocrinol 2017; 5: 816-826.
  • 48. Bird S. Consent to medical treatment: the mature minor. Aust Fam Physician 2011; 40: 159-160.
  • 49. Marinkovic M, Newfield RS. Chest reconstructive surgeries in transmasculine youth: experience from one pediatric center. Int J Transgend 2017. 18: 376-381.
  • 50. Milrod C, Karasic D. Age is just a number: WPATH-affiliated surgeons’ experiences and attitudes toward vaginoplasty in transgender females under 18 years of age in the United States. J Sex Med 2017; 14: 624-634.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.